Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer, February 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 185 articles:
HTML format


 

Single Articles

  1. OKONOGI N, Kobayashi D, Suga T, Imai T, et al
    Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer.
    Oncol Lett. 2018;15:459-466.
    Abstract    

    Abstract available

  2. SHU L, Zhang Z, Cai Y
    MicroRNA-204 inhibits cell migration and invasion in human cervical cancer by regulating transcription factor 12.
    Oncol Lett. 2018;15:161-166.
    Abstract    

    Abstract available

  3. TAO P, Wen H, Yang B, Zhang A, et al
    miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.
    Exp Ther Med. 2018;15:562-568.
    Abstract    

    Abstract available

  4. ZHU Y, Zhang AJ, Wu DB, Shen Z, et al
    Prognostic significance of the pretreatment serum gamma-glutamyltransferase levels in Chinese patients with non-metastatic cervical cancer.
    Oncotarget. 2017;8:115701-115708.
    Abstract    

    Abstract available

  5. YANG W, Tan W, Zheng J, Zhang B, et al
    MEHP promotes the proliferation of cervical cancer via GPER mediated activation of Akt.
    Eur J Pharmacol. 2018 Jan 27. pii: S0014-2999(18)30054.
    Abstract    

    Abstract available

  6. RAD A, Sorbye SW, Dreyer G, Hovland S, et al
    HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests.
    Medicine (Baltimore). 2017;96:e8752.
    Abstract    

    Abstract available

  7. LIU YM, Ni LQ, Wang SS, Lv QL, et al
    Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study.
    World J Surg Oncol. 2018;16:18.
    Abstract    

    Abstract available

  8. HWANG JP, Ahmed S, Ariza-Heredia EJ, Duan Z, et al
    Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant.
    Biol Blood Marrow Transplant. 2018 Jan 25. pii: S1083-8791(18)30035.
    Abstract    

    Abstract available

  9. LAENGSRI V, Kerdpin U, Plabplueng C, Treeratanapiboon L, et al
    Cervical Cancer Markers: Epigenetics and microRNAs.
    Lab Med. 2018 Jan 25. pii: 4825038. doi: 10.1093.
    Abstract    

    Abstract available

  10. ABE K, Kadoya N, Sato S, Hashimoto S, et al
    Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer.
    J Radiat Res. 2018 Jan 25. pii: 4825046. doi: 10.1093.
    Abstract    

    Abstract available

  11. YOU W, Li S, Du R, Zheng J, et al
    Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.
    Exp Ther Med. 2018;15:412-418.
    Abstract    

    Abstract available

  12. SAH SK, Gonzalez JV, Shrestha S, Adhikari A, et al
    Human papillomavirus genotype distribution in cervical cancer biopsies from Nepalese women.
    Infect Agent Cancer. 2018;13:4.
    Abstract    

    Abstract available

  13. HE Y, Huang Y, Li N, Yan H, et al
    [Expression of IRX1 in cervical cancer and its correlation with clinical stage of cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2018;98:222-226.
    Abstract    

    Abstract available

  14. HATA M, Koike I, Miyagi E, Asai-Sato M, et al
    Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care.
    Anticancer Res. 2018;38:1033-1040.
    Abstract    

    Abstract available

  15. CANFELL K, Saville M, Caruana M, Gebski V, et al
    Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    BMJ Open. 2018;8:e016700.
    Abstract    

    Abstract available

  16. BANDYOPADHYAY A, Mukherjee U, Ghosh S, Ghosh S, et al
    Pattern of Failure with Locally Advanced Cervical Cancer- A Retrospective Audit and Analysis of Contributory Factors
    Asian Pac J Cancer Prev. 2018;19:73-79.
    Abstract    

    Abstract available

  17. HAFEZ HN, El-Gazzar ABA
    Synthesis and evaluation of antitumor activity of new 4-substituted thieno[3,2-d]pyrimidine and thienotriazolopyrimidine derivatives.
    Acta Pharm. 2017;67:527-542.
    Abstract    

    Abstract available

  18. GODEVAC D, Damjanovic A, Stanojkovic TP, Andelkovic B, et al
    Identification of cytotoxic metabolites from Mahonia aquifolium using (1)H NMR-based metabolomics approach.
    J Pharm Biomed Anal. 2018;150:9-14.
    Abstract    

    Abstract available

  19. DAVIES P, Valuta D, Cojohari N, Sancho-Garnier H, et al
    Implementing an organised cervical screening programme in the Republic of Moldova-Stakeholder identification and engagement.
    Cancer Epidemiol. 2017;50.
    Abstract    

    Abstract available

  20. GULTEKIN M, Dundar S, Kucukyildiz I, Karaca MZ, et al
    Survival of gynecological cancers in Turkey: where are we at?
    J Gynecol Oncol. 2017;28:e85.
    Abstract    

    Abstract available

  21. WU SG, Sun JY, He ZY, Chen QH, et al
    Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.
    J Gynecol Oncol. 2017;28:e81.
    Abstract    

    Abstract available

  22. TAN Z, Li A, Chen L, Xu X, et al
    Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy.
    J Korean Med Sci. 2017;32:1891-1895.
    Abstract    

    Abstract available

  23. WILKINSON EJ
    Doctors in Denial: The Forgotten Women in the "Unfortunate Experiment".
    J Low Genit Tract Dis. 2017;21:336.
    Abstract    

    Abstract available

  24. CEBALLOS KM, Lee M, Cook DA, Smith LW, et al
    Post-Loop Electrosurgical Excision Procedure High-Risk Human Papillomavirus Testing as a Test of Cure: The British Columbia Experience.
    J Low Genit Tract Dis. 2017;21:284-288.
    Abstract    

    Abstract available

  25. CIAVATTINI A, Clemente N, Liverani CA, Cattani P, et al
    Cervical Excision Procedure: A Trend of Decreasing Length of Excision Observed in a Multicenter Survey.
    J Low Genit Tract Dis. 2017;21:279-283.
    Abstract    

    Abstract available

  26. HILAL Z, Rezniczek GA, El-Fizazi N, Tempfer CB, et al
    Large Loop Excision of the Transformation Zone Versus True Cone Biopsy Electrode Excision: A Randomized Trial.
    J Low Genit Tract Dis. 2017;21:272-278.
    Abstract    

    Abstract available

  27. DEMARCO M, Lorey TS, Fetterman B, Cheung LC, et al
    Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    J Low Genit Tract Dis. 2017;21:261-267.
    Abstract    

    Abstract available

  28. MAYEAUX EJ JR, Novetsky AP, Chelmow D, Choma K, et al
    Systematic Review of International Colposcopy Quality Improvement Guidelines.
    J Low Genit Tract Dis. 2017;21:249-257.
    Abstract    

    Abstract available

  29. MAYEAUX EJ JR, Novetsky AP, Chelmow D, Garcia F, et al
    ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States.
    J Low Genit Tract Dis. 2017;21:242-248.
    Abstract    

    Abstract available

  30. WAXMAN AG, Conageski C, Silver MI, Tedeschi C, et al
    ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.
    J Low Genit Tract Dis. 2017;21:235-241.
    Abstract    

    Abstract available

  31. WENTZENSEN N, Schiffman M, Silver MI, Khan MJ, et al
    ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.
    J Low Genit Tract Dis. 2017;21:230-234.
    Abstract    

    Abstract available

  32. KHAN MJ, Werner CL, Darragh TM, Guido RS, et al
    ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.
    J Low Genit Tract Dis. 2017;21:223-229.
    Abstract    

    Abstract available

  33. KETELAARS PJW, Buskes MHM, Bosgraaf RP, van Hamont D, et al
    The effect of video information on anxiety levels in women attending colposcopy: a randomized controlled trial.
    Acta Oncol. 2017;56:1728-1733.
    Abstract    

    Abstract available

  34. STANCULESCU RV, Bratila E, Bausic V, Vladescu TC, et al
    Review of the biotechnologies and tests used for precancerous cervical lesions diagnosis.
    Rom J Morphol Embryol. 2017;58:7-14.
    Abstract    

    Abstract available

  35. FOKOM DOMGUE J, Schiffman M, Wentzensen NH, Gage JC, et al
    Assessment of a new lower-cost real-time PCR detection assay for high-risk HPV: Useful for cervical screening in limited resource settings?
    J Clin Microbiol. 2017 May 17. pii: JCM.00492-17. doi: 10.1128/JCM.00492.
    Abstract    

    Abstract available

  36. ANNEDE P, Gouy S, Mazeron R, Bentivegna E, et al
    Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.
    Oncologist. 2017;22:182-188.
    Abstract    

    Abstract available

  37. BALMANT NV, de Souza Reis R, de Oliveira Santos M, Pinto Oliveira J, et al
    Trends in Cancer Mortality Among Adolescents and Young Adults in Brazil.
    J Adolesc Young Adult Oncol. 2017;6:341-347.
    Abstract    

    Abstract available

  38. POTOCNJAK I, Gobin I, Domitrovic R
    Carvacrol induces cytotoxicity in human cervical cancer cells but causes cisplatin resistance: Involvement of MEK-ERK activation.
    Phytother Res. 2018 Feb 8. doi: 10.1002/ptr.6048.
    Abstract    

    Abstract available

  39. STARRACH T, Gallwas J, Blankenstein T, Mahner S, et al
    [Changes to cervical cancer screening in Germany].
    MMW Fortschr Med. 2018;160:46-51.
    Abstract    



  40. GANA GJ, Oche MO, Ango JT, Kaoje AU, et al
    Educational intervention on knowledge of cervical cancer and uptake of Pap smear test among market women in Niger State, Nigeria.
    J Public Health Afr. 2017;8:575.
    Abstract    

    Abstract available

  41. ZHENG D, Mou HP, Diao P, Li XM, et al
    Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients.
    Oncotarget. 2017;9:2866-2875.
    Abstract    

    Abstract available

  42. LU H, Guo R, Yang H, Wang H, et al
    The prognostic value of negative lymph node count for patients with cervical cancer after radical surgery.
    Oncotarget. 2017;9:2810-2818.
    Abstract    

    Abstract available

  43. HAN D, Wang J, Cheng G
    LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.
    Oncotarget. 2017;9:2395-2409.
    Abstract    

    Abstract available

  44. LEE JW, Yang DH, Park S, Han HK, et al
    Trichostatin A resistance is facilitated by HIF-1alpha acetylation in HeLa human cervical cancer cells under normoxic conditions.
    Oncotarget. 2017;9:2035-2049.
    Abstract    

    Abstract available

  45. KIM W, Pyo J, Noh BJ, Jeong JW, et al
    CCAR2 negatively regulates IL-8 production in cervical cancer cells.
    Oncotarget. 2017;9:1143-1155.
    Abstract    

    Abstract available

  46. XU S, Du X, Feng G, Zhang Y, et al
    Efficient inhibition of cervical cancer by dual drugs loaded in biodegradable thermosensitive hydrogel composites.
    Oncotarget. 2017;9:282-292.
    Abstract    

    Abstract available

  47. ALEKSIOSKA-PAPESTIEV I, Chibisheva V, Micevska M, Dimitrov G, et al
    Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Med Arch. 2018;72:26-30.
    Abstract    

    Abstract available

  48. STEWART TS, Moodley J, Walter FM
    Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
    Cancer Epidemiol. 2018;53:81-92.
    Abstract    

    Abstract available

  49. XU Y, Ru T, Zhu L, Liu B, et al
    Ultrasonic histogram assessment of early response to concurrent chemo-radiotherapy in patients with locally advanced cervical cancer: a feasibility study.
    Clin Imaging. 2018;49:144-149.
    Abstract    

    Abstract available

  50. DAS M
    Cervical cancer vaccine controversy in India.
    Lancet Oncol. 2018;19:e84.
    Abstract    



  51. RIBEIRO CM, Silva GAE
    Assessment of the production of cervical cancer care procedures in the Brazilian National Health System in 2015.
    Epidemiol Serv Saude. 2018;27:e20172124.
    Abstract    

    Abstract available

  52. FALK D
    A Mixed Methods Review of Education and Patient Navigation Interventions to Increase Breast and Cervical Cancer Screening for Rural Women.
    Soc Work Public Health. 2018 Feb 7:1-14. doi: 10.1080/19371918.2018.1434583.
    Abstract    

    Abstract available

  53. ZHANG S, McNamara M, Batur P
    Cervical Cancer Screening: What's New? Updates for the Busy Clinician.
    Am J Med. 2018 Feb 2. pii: S0002-9343(18)30095.
    Abstract    

    Abstract available

  54. PETKEVICIENE J, Ivanauskiene R, Klumbiene J
    Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014.
    Public Health. 2018;156:79-86.
    Abstract    

    Abstract available

  55. LASKAR S, Sanchez-Sanchez L, Flores SM, Lopez-Munoz H, et al
    Identification of (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamate-nitrostyrene hybrid as potent antiproliferative and apoptotic inducing agent against cervical cancer cell lines.
    Eur J Med Chem. 2018;146:621-635.
    Abstract    

    Abstract available

  56. YOKCHOM R, Laiwejpithaya S, Maneeprakorn W, Tapaneeyakorn S, et al
    Paper-based immunosensor with signal amplification by enzyme-labeled anti-p16(INK4a) multifunctionalized gold nanoparticles for cervical cancer screening.
    Nanomedicine. 2018 Feb 3. pii: S1549-9634(18)30027.
    Abstract    

    Abstract available

  57. SKLIARENKO J, Carlone M, Tanderup K, Han K, et al
    Technique adaptation, strategic replanning, and team learning during implementation of MR-guided brachytherapy for cervical cancer.
    Brachytherapy. 2018;17:86-93.
    Abstract    

    Abstract available

  58. WANG N, Wang Z, Xu Z, Chen X, et al
    A cisplatin-loaded immuno-chemotherapeutic nanohybrid bearing immune checkpoint inhibitors for enhanced cervical cancer therapy.
    Angew Chem Int Ed Engl. 2018 Feb 5. doi: 10.1002/anie.201800422.
    Abstract    

    Abstract available

  59. EMMETT M, Gildea C, Nordin A, Hirschowitz L, et al
    Cervical cancer - does the morphological subtype affect survival rates?
    J Obstet Gynaecol. 2018 Feb 6:1-8. doi: 10.1080/01443615.2017.1379062.
    Abstract    

    Abstract available

  60. FENG YC, Ji WL, Yue N, Huang YC, et al
    The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance.
    Cancer Manag Res. 2018;10:105-113.
    Abstract    

    Abstract available

  61. LIN YH, Hsiao YH, Yang SF, Liu YF, et al
    Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.
    Reprod Sci. 2018 Jan 1:1933719118756749. doi: 10.1177/1933719118756749.
    Abstract    

    Abstract available

  62. LI J, Chen L, Liu Q, Tang M, et al
    Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
    Cancer Biol Ther. 2018 Feb 5:0. doi: 10.1080/15384047.2018.1433504.
    Abstract    

    Abstract available

  63. SHIM SH, Kim SN, Chae SH, Kim JE, et al
    Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis.
    J Gynecol Oncol. 2018 Jan 5. pii: 29.e25. doi: 10.3802/jgo.2018.
    Abstract    

    Abstract available

  64. MIKAMI M, Shida M, Shibata T, Katabuchi H, et al
    Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer.
    J Gynecol Oncol. 2017 Dec 27. pii: 29.e23. doi: 10.3802/jgo.2018.
    Abstract    

    Abstract available

  65. THO D, Racine E, Easton H, Song WY, et al
    Technical Note: On EM Reconstruction of a Multi Channel Shielded Applicator for Cervical Cancer Brachytherapy: A Feasibility Study.
    Med Phys. 2018 Feb 5. doi: 10.1002/mp.12789.
    Abstract    

    Abstract available

  66. JIA L, Li F, Shao M, Zhang W, et al
    IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells.
    Oncol Lett. 2018;15:1350-1356.
    Abstract    

    Abstract available

  67. WANG P, Zhang L, Zhang J, Xu G, et al
    MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.
    Exp Ther Med. 2018;15:1385-1393.
    Abstract    

    Abstract available


  68. Immunotherapy: A New Strategy for the Treatment of Cervical Cancer. Interview with Dr. Christian Marth and Dr. Sharad Ghamande.
    Med Sci (Basel). 2018;6.
    Abstract    

    Abstract available

  69. YU X, Liu Y, Wang Y, Mao X, et al
    Baicalein induces cervical cancer apoptosis through the NF-kappaB signaling pathway.
    Mol Med Rep. 2018 Jan 25. doi: 10.3892/mmr.2018.8493.
    Abstract    

    Abstract available

  70. RYU H, Song IC, Choi YS, Yun HJ, et al
    ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy.
    Medicine (Baltimore). 2017;96:e9402.
    Abstract    

    Abstract available

  71. LILI E, Chatzistamatiou K, Kalpaktsidou-Vakiani A, Moysiadis T, et al
    Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up.
    Medicine (Baltimore). 2018;97:e9719.
    Abstract    

    Abstract available

  72. SITOLE BN, Mavri-Damelin D
    Peroxidasin is regulated by the epithelial-mesenchymal transition master transcription factor Snai1.
    Gene. 2018;646:195-202.
    Abstract    

    Abstract available

  73. LOKE AY, Kwan ML, Wong YT, Wong AKY, et al
    The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review.
    J Prim Care Community Health. 2017;8:349-362.
    Abstract    

    Abstract available

  74. GOMEZ MC, Abaunza MC, Vargas EJ, Acosta I, et al
    [Squamous cell carcinoma in situ of the cervix and placental site nodule: Case report].
    Gac Med Mex. 2017;153:397-400.
    Abstract    

    Abstract available

  75. ANGHEL RM, Trifanescu OG, Mitrica RI, Curea FG, et al
    Good Prognosis Went Badly: Fulminant Evolution of a 29-Year-Old Patient with Verrucous Carcinoma of the Cervix.
    J Adolesc Young Adult Oncol. 2017;6:499-502.
    Abstract    

    Abstract available

  76. D'ADDARIO M, Redmond S, Scott P, Egli-Gany D, et al
    Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30448.
    Abstract    

    Abstract available

  77. LUND KV, Simonsen TG, Kristensen GB, Rofstad EK, et al
    Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
    Acta Oncol. 2017;56:675-681.
    Abstract    

    Abstract available

  78. OKAZAWA-SAKAI M, Yokoyama T, Fujimoto E, Okame S, et al
    Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
    Int J Clin Oncol. 2018 Feb 14. pii: 10.1007/s10147-018-1249.
    Abstract    

    Abstract available

  79. AKHAVAN S, Aminimoghaddam S, Rahmani M
    Sentinel lymph node in cervical cancer.
    Med J Islam Repub Iran. 2017;31:50.
    Abstract    

    Abstract available

  80. GEREMEW AB, Gelagay AA, Azale T
    Comprehensive knowledge on cervical cancer, attitude towards its screening and associated factors among women aged 30-49 years in Finote Selam town, northwest Ethiopia.
    Reprod Health. 2018;15:29.
    Abstract    

    Abstract available

  81. COBO-CUENCA AI, Rodriguez-Borrego MA, Hidalgo-Lopezosa P, Rodriguez-Munoz PM, et al
    Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14).
    Eur J Public Health. 2018 Feb 12. pii: 4851227. doi: 10.1093.
    Abstract    

    Abstract available

  82. TAKAGI H, Sakamoto J, Osaka Y, Shibata T, et al
    Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.
    Medicine (Baltimore). 2018;97:e9856.
    Abstract    

    Abstract available

  83. SHIFERAW S, Addissie A, Gizaw M, Hirpa S, et al
    Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV-positive women attending public health centers in Addis Ababa city, Ethiopia.
    Cancer Med. 2018 Feb 14. doi: 10.1002/cam4.1334.
    Abstract    

    Abstract available

  84. GARCIA-ORTEGA DY, Reyes-Garcia N, Martinez-Said H, Caro-Sanchez CHS, et al
    Radiation-induced leiomyosarcoma of the rectum after cervical cancer treatment.
    Rev Gastroenterol Mex. 2018 Feb 10. pii: S0375-0906(18)30017.
    Abstract    



  85. TIAN R, Li X, Gao Y, Li Y, et al
    Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
    Int J Oncol. 2018 Feb 7. doi: 10.3892/ijo.2018.4267.
    Abstract    

    Abstract available

  86. LI J, Zhang Y, Chen L, Lu X, et al
    Cervical Cancer HeLa Cell Autocrine Apoptosis Induced by Co-immobilized TNF-alpha plus IFN-gamma Biomaterials.
    ACS Appl Mater Interfaces. 2018 Feb 13. doi: 10.1021/acsami.7b18277.
    Abstract    

    Abstract available

  87. LIU X, Peng J, He J, Li Q, et al
    Selection and identification of novel peptides specifically targeting human cervical cancer.
    Amino Acids. 2018 Feb 12. pii: 10.1007/s00726-018-2539.
    Abstract    

    Abstract available

  88. YANO M, Ikeda Y, Kato T, Sakaki M, et al
    A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer.
    Mol Clin Oncol. 2018;8:302-305.
    Abstract    

    Abstract available

  89. PRASANNA R, Bunger D, Khan MA
    Efficacy and safety of DoceAqualip in a patient with locally advanced cervical cancer: A case report.
    Mol Clin Oncol. 2018;8:296-299.
    Abstract    

    Abstract available

  90. YOSHIDA K, Kajiyama H, Utsumi F, Niimi K, et al
    A post-recurrence survival-predicting indicator for cervical cancer from the analysis of 165 patients who developed recurrence.
    Mol Clin Oncol. 2018;8:281-285.
    Abstract    

    Abstract available

  91. IDA N, Nakamura K, Saijo M, Kusumoto T, et al
    Prognostic nutritional index as a predictor of survival in patients with recurrent cervical cancer.
    Mol Clin Oncol. 2018;8:257-263.
    Abstract    

    Abstract available

  92. ZHANG T, Jiao J, Jiao X, Zhao L, et al
    Aberrant frequency of TNFR2(+) Treg and related cytokines in patients with CIN and cervical cancer.
    Oncotarget. 2017;9:5073-5083.
    Abstract    

    Abstract available

  93. KIM MJ, Choi MY, Lee DH, Roh GS, et al
    O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer.
    Oncotarget. 2017;9:4625-4636.
    Abstract    

    Abstract available

  94. MAO JJ, Wu LX, Wang W, Ye YY, et al
    Nucleotide variation in ATG4A and susceptibility to cervical cancer in Southwestern Chinese women.
    Oncol Lett. 2018;15:2992-3000.
    Abstract    

    Abstract available

  95. LI MY, Liu JQ, Chen DP, Li ZY, et al
    p68 prompts the epithelial-mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF-beta1 signaling pathway.
    Oncol Lett. 2018;15:2111-2116.
    Abstract    

    Abstract available

  96. DAN VM, Muralikrishnan B, Sanawar R, J S V, et al
    Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines.
    Sci Rep. 2018;8:2810.
    Abstract    

    Abstract available

  97. GATOS KC
    A Literature Review of Cervical Cancer Screening in Transgender Men.
    Nurs Womens Health. 2018;22:52-62.
    Abstract    

    Abstract available

  98. BINKA C, Nyarko SH, Awusabo-Asare K, Doku DT, et al
    "I always tried to forget about the condition and pretend I was healed": coping with cervical cancer in rural Ghana.
    BMC Palliat Care. 2018;17:24.
    Abstract    

    Abstract available

  99. GRJIBOVSKI AM, Dubovichenko D, Saduakassova S, Zhatkanbayeva G, et al
    Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study.
    Int Health. 2018 Feb 8. pii: 4843995. doi: 10.1093.
    Abstract    

    Abstract available

  100. HASEGAWA K, Ikeda Y, Kunugi Y, Kurosaki A, et al
    Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer.
    J Immunother. 2018 Feb 9. doi: 10.1097/CJI.0000000000000214.
    Abstract    

    Abstract available

  101. GUPTA S, Maheshwari A, Parab P, Mahantshetty U, et al
    Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2018 Feb 12:JCO2017759985. doi: 10.1200/JCO.2017.75.9985.
    Abstract    

    Abstract available

  102. LIU F, Dai M, Xu Q, Zhu X, et al
    SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-kappaB-CD47 axis.
    Oncogene. 2018 Feb 12. pii: 10.1038/s41388-017-0119.
    Abstract    

    Abstract available

  103. HSIEH HY, Huang JW, Lu CH, Lin JC, et al
    Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    J Formos Med Assoc. 2018 Feb 8. pii: S0929-6646(17)30732.
    Abstract    

    Abstract available

  104. VAZQUEZ-VICENTE D, Del Bas BF, Villayzan JG, Arranz JP, et al
    Retroperitoneal laparoscopic paraaortic lymphadenectomy in paraaortical staging of locally advanced cervical cancer.
    J Minim Invasive Gynecol. 2018 Feb 7. pii: S1553-4650(18)30110.
    Abstract    

    Abstract available

  105. CHEN S, Lv M, Fang S, Ye W, et al
    Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes.
    Int J Biol Macromol. 2018 Feb 7. pii: S0141-8130(17)34155.
    Abstract    

    Abstract available

  106. OTTER S, Coates A, Franklin A, Cunningham M, et al
    Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer.
    Brachytherapy. 2018 Feb 6. pii: S1538-4721(18)30003.
    Abstract    

    Abstract available

  107. JOHNSON LG, Armstrong A, Joyce CM, Teitelman AM, et al
    Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review.
    Implement Sci. 2018;13:28.
    Abstract    

    Abstract available

  108. LIU YL, Wang GQ, Cui HX, Li XX, et al
    miRNA211 induces apoptosis of cervical cancer SiHa cells via down-regulation of inhibitor of apoptosis proteins.
    Eur Rev Med Pharmacol Sci. 2018;22:336-342.
    Abstract    

    Abstract available

  109. VALDES G, Interian Y
    Comment on 'Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: a feasibility study'.
    Phys Med Biol. 2018 Feb 9. doi: 10.1088/1361-6560.
    Abstract    

    Abstract available

  110. OKATCH H, Sowicz TJ, Teng H, Ramogola-Masire D, et al
    Achieving public and global health competencies: A teaching case study of Botswana's cervical cancer screening program.
    Public Health Nurs. 2018 Feb 9. doi: 10.1111/phn.12389.
    Abstract    

    Abstract available

  111. NWACHUKWU CR, Mayadev J, Viswanathan AN
    Concurrent Chemoradiotherapy for Stage IIIB Cervical Cancer-Global Impact Through Power.
    JAMA Oncol. 2018 Feb 8. pii: 2671603. doi: 10.1001/jamaoncol.2017.5078.
    Abstract    



  112. GRIGSBY P, Elhammali A, Ruiz F, Markovina S, et al
    Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer.
    Oncotarget. 2017;9:4061-4073.
    Abstract    

    Abstract available

  113. GALLOTTA V, Conte C, Federico A, Vizzielli G, et al
    Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study.
    Eur J Surg Oncol. 2018 Feb 5. pii: S0748-7983(18)30129.
    Abstract    

    Abstract available

  114. CHAI W, Gong F, Zhang W, Wen Y, et al
    Multiple primary cancer in the female genital system: Two rare case reports and a literature review.
    Medicine (Baltimore). 2017;96:e8860.
    Abstract    

    Abstract available

  115. YOUNG SA, Gupta R, Neccuzi J
    New Schedule for Administering HPV Vaccinations.
    W V Med J. 2017;113:26-7.
    Abstract    



  116. CHEN WQ, Li H, Sun KX, Zheng RS, et al
    [Report of Cancer Incidence and Mortality in China, 2014].
    Zhonghua Zhong Liu Za Zhi. 2018;40:5-13.
    Abstract    

    Abstract available

  117. GOLUBOVIC M, Lopicic M, Terzic N, Durovic M, et al
    Presence of histopathological premalignant lesions and infection caused by high-risk genotypes of human papillomavirus in patients with suspicious cytological and colposcopy results: A prospective study.
    Vojnosanit Pregl. 2017;74:24-30.
    Abstract    

    Abstract available

  118. KOISS R, Boncz I, Hernadi Z, Szentirmay Z, et al
    [Proposal for the modernization of cervical screening procedure in Hungary].
    Orv Hetil. 2017;158:2062-2067.
    Abstract    

    Abstract available

  119. LEW JB, Simms KT, Smith MA, Hall M, et al
    Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lancet Public Health. 2017;2:e96-e107.
    Abstract    

    Abstract available

  120. YOSHIDA Y, Schmaltz CL, Jackson-Thompson J, Simoes EJ, et al
    The impact of screening on cancer incidence and mortality in Missouri, USA, 2004-2013.
    Public Health. 2018;154:51-58.
    Abstract    

    Abstract available

  121. KANAO H, Aoki Y, Kato K, Matoda M, et al
    Total Laparoscopic Resection Surgery for a Cervical Carcinoma that Recurred in the Pelvic Sidewall After Radical Hysterectomy and Adjuvant Concurrent Chemoradiotherapy.
    J Minim Invasive Gynecol. 2017;24:899-900.
    Abstract    

    Abstract available

  122. PANDURANGAN M, Enkhtaivan G, Mistry B, Patel RV, et al
    beta-Alanine intercede metabolic recovery for amelioration of human cervical and renal tumors.
    Amino Acids. 2017;49:1373-1380.
    Abstract    

    Abstract available

  123. NAVARRO-ILLANA E, Lopez-Lacort M, Navarro-Illana P, Vilata JJ, et al
    Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Vaccine. 2017 May 9. pii: S0264-410X(17)30581.
    Abstract    

    Abstract available

  124. PERKINS RB, Lin M, Wallington SF, Hanchate A, et al
    Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents.
    Sex Transm Dis. 2017;44:365-370.
    Abstract    

    Abstract available

  125. AREDES MA, Garcez MR, Chaves GV
    Influence of chemoradiotherapy on nutritional status, functional capacity, quality of life and toxicity of treatment for patients with cervical cancer.
    Nutr Diet. 2018 Feb 21. doi: 10.1111/1747-0080.12414.
    Abstract    

    Abstract available

  126. LEE JH, Kim H, Choi H, Jeong H, et al
    Contributions and Limitations of National Cervical Cancer Screening Program in Korea; A Retrospective Observational Study.
    Asian Nurs Res (Korean Soc Nurs Sci). 2018 Jan 2. pii: S1976-1317(17)30364.
    Abstract    

    Abstract available

  127. WOLFORD JE, Tewari KS
    Rational Design for Cervical Cancer Therapeutics: Cellular and Non-Cellular Based Strategies on the Horizon for Recurrent, Metastatic or Refractory Cervical Cancer.
    Expert Opin Drug Discov. 2018 Feb 21. doi: 10.1080/17460441.2018.1443074.
    Abstract    

    Abstract available

  128. MEI J, Wang DH, Wang LL, Chen Q, et al
    MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.
    Eur Rev Med Pharmacol Sci. 2018;22:623-631.
    Abstract    

    Abstract available

  129. KOC Z, Ozdes EK, Topatan S, Cinarli T, et al
    The Impact of Education About Cervical Cancer and Human Papillomavirus on Women's Healthy Lifestyle Behaviors and Beliefs: Using the PRECEDE Educational Model.
    Cancer Nurs. 2018 Feb 14. doi: 10.1097/NCC.0000000000000570.
    Abstract    

    Abstract available

  130. KUSUNOKI S, Huang KG, Magno A
    Laparoscopic en bloc resection of a para-cervical cancer with OHVIRA syndrome.
    Taiwan J Obstet Gynecol. 2018;57:141-143.
    Abstract    

    Abstract available

  131. BOGANI G, Leone Roberti Maggiore U, Signorelli M, Martinelli F, et al
    The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.
    Crit Rev Oncol Hematol. 2018;122:92-97.
    Abstract    

    Abstract available

  132. WANG P, Zhai G, Bai Y
    Values of miR-34a and miR-218 expression in the diagnosis of cervical cancer and the prediction of prognosis.
    Oncol Lett. 2018;15:3580-3585.
    Abstract    

    Abstract available

  133. SHAN D, Shang Y, Hu T
    Long noncoding RNA BLACAT1 promotes cell proliferation and invasion in human cervical cancer.
    Oncol Lett. 2018;15:3490-3495.
    Abstract    

    Abstract available

  134. CHENG L, Kong B, Zhao Y, Jiang J, et al
    miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.
    Oncol Lett. 2018;15:3075-3080.
    Abstract    

    Abstract available

  135. SHEN LL, Muo CH, Su SY, Morisky DE, et al
    Use of Chinese Medicine Reduces the Development of Cervical Cancer from Pap Smear-Diagnosed Cervical Dysplasia: A Case-Control Study.
    Evid Based Complement Alternat Med. 2017;2017:4082630.
    Abstract    

    Abstract available

  136. RYMSZA T, Ribeiro EA, de Carvalho LFDCES, Bhattacharjee T, et al
    Human papillomavirus detection using PCR and ATR-FTIR for cervical cancer screening.
    Spectrochim Acta A Mol Biomol Spectrosc. 2018;196:238-246.
    Abstract    

    Abstract available

  137. KATKI HA, Schiffman M
    A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations.
    Prev Med. 2018 Feb 14. pii: S0091-7435(18)30040.
    Abstract    

    Abstract available

  138. NGERNYUANG N, Shao R, Suwannarurk K, Limpaiboon T, et al
    Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer.
    Pathology. 2018 Feb 13. pii: S0031-3025(17)30292.
    Abstract    

    Abstract available

  139. WU SW, Chen T, Pan Q, Wei LY, et al
    Cost Analysis of Cervical Cancer Patients with Different Medical Payment Modes Based on Gamma Model within a Grade A Tertiary Hospital.
    Chin Med J (Engl). 2018;131:389-394.
    Abstract    

    Abstract available

  140. ROTHBERG MB, Hu B, Lipold L, Schramm S, et al
    A risk prediction model to allow personalized screening for cervical cancer.
    Cancer Causes Control. 2018 Feb 15. pii: 10.1007/s10552-018-1013.
    Abstract    

    Abstract available

  141. ZHANG W, Xiong Z, Wei T, Li Q, et al
    Nuclear factor 90 promotes angiogenesis by regulating HIF-1alpha/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer.
    Cell Death Dis. 2018;9:276.
    Abstract    

    Abstract available

  142. CHEN CS, Park S, Shin JH, Nouri Y, et al
    Endovascular treatment for the control of active vaginal bleeding from uterine cervical cancer treated with radiotherapy.
    Acta Radiol. 2018 Jan 1:284185118758133. doi: 10.1177/0284185118758133.
    Abstract    

    Abstract available

  143. TANG Z, Xu Y, Song N, Zou D, et al
    A comparison of the MeltPro((R)) HPV Test with the Cobas((R)) HPV Test for detecting and genotyping 14 high-risk human papillomavirus types.
    Arch Virol. 2018;163:725-730.
    Abstract    

    Abstract available

  144. HARIRI TABRIZI S, Farzaneh F, Aghamiri SMR, Arab M, et al
    Comparison between performance of single-fiber reflectance spectroscopy (SFRS) system and colposcopy: a phase III trial.
    Lasers Med Sci. 2017;32:2139-2144.
    Abstract    

    Abstract available

  145. TAKAGI R, Takeda A, Takahashi D, Toshima K, et al
    Target-Selective Fluorescence Imaging and Photocytotoxicity against H2 O2 High-Expressing Cancer Cells Using a Photoactivatable Theranostic Agent.
    Chem Asian J. 2017;12:2656-2659.
    Abstract    

    Abstract available

  146. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    Abstract    

    Abstract available

  147. TORHEIM T, Malinen E, Hole KH, Lund KV, et al
    Autodelineation of cervical cancers using multiparametric magnetic resonance imaging and machine learning.
    Acta Oncol. 2017;56:806-812.
    Abstract    

    Abstract available

  148. MARTINEZ P, Del Campo JM
    Pembrolizumab in recurrent advanced cervical squamous carcinoma.
    Immunotherapy. 2017;9:467-470.
    Abstract    

    Abstract available

  149. BERTI FCB, Pereira APL, Cebinelli GCM, Trugilo KP, et al
    The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
    Cytokine Growth Factor Rev. 2017;34:1-13.
    Abstract    

    Abstract available

  150. RAMACHANDRAN B
    Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis.
    Endocr Relat Cancer. 2017;24:R99-R108.
    Abstract    

    Abstract available

  151. DUNN SF, Lofters AK, Ginsburg OM, Meaney CA, et al
    Cervical and Breast Cancer Screening After CARES: A Community Program for Immigrant and Marginalized Women.
    Am J Prev Med. 2017;52:589-597.
    Abstract    

    Abstract available

  152. GERMAR MJ, Purugganan C, Bernardino MS, Cuenca B, et al
    Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule.
    Hum Vaccin Immunother. 2017;13:1158-1166.
    Abstract    

    Abstract available

  153. PEDERSEN K, Fogelberg S, Thamsborg LH, Clements M, et al
    An overview of cervical cancer epidemiology and prevention in Scandinavia.
    Acta Obstet Gynecol Scand. 2018 Feb 1. doi: 10.1111/aogs.13313.
    Abstract    

    Abstract available

  154. IKOMA S, Nicolas M, Jagirdar J, Policarpio-Nicolas ML, et al
    Chondrosarcoma-like metastasis from a poorly differentiated uterine cervical squamous cell carcinoma. A unique morphology and diagnostic pitfall in cytology.
    Diagn Cytopathol. 2017 Apr 14. doi: 10.1002/dc.23721.
    Abstract    

    Abstract available

  155. PETRY KU, Barth C, Wasem J, Neumann A, et al
    A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany.
    Eur J Obstet Gynecol Reprod Biol. 2017;212:132-139.
    Abstract    

    Abstract available

  156. THARAVICHITKUL E, Chakrabandhu S, Klunklin P, Onchan W, et al
    Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer.
    Gynecol Oncol. 2018 Feb 2. pii: S0090-8258(18)30047.
    Abstract    

    Abstract available

  157. ZHANG HR, Lai SY, Huang LJ, Zhang ZF, et al
    Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30065.
    Abstract    

    Abstract available

  158. YANG Y, Wu Q, Li N, Che S, et al
    Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome.
    Hum Pathol. 2018 Feb 13. pii: S0046-8177(18)30046.
    Abstract    

    Abstract available

  159. LECAVALIER-BARSOUM M, Chaudary N, Han K, Koritzinsky M, et al
    Targeting the CXCL12/CXCR4 Pathway and Myeloid Cells to Improve Radiation Treatment of Locally Advanced Cervical Cancer.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31297.
    Abstract    

    Abstract available

  160. MAGED AM, Saad H, Salah E, Meshaal H, et al
    Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening.
    Int J Gynaecol Obstet. 2018 Jan 31. doi: 10.1002/ijgo.12453.
    Abstract    

    Abstract available

  161. YANG L, Zheng A, Zhang X, Fang X, et al
    Clear Cell Carcinoma of the Uterine Cervix: A Clinical and Pathological Analysis of 47 Patients Without Intrauterine Diethylstilbestrol Exposure.
    Int J Gynecol Cancer. 2017;27:1009-1014.
    Abstract    

    Abstract available

  162. LIU CZ, Zeng HX, Zhao JJ, Rong Y, et al
    The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Int J Gynecol Cancer. 2017;27:994-1000.
    Abstract    

    Abstract available

  163. GUNTUPALLI SR, Sheeder J, Ioffe Y, Tergas A, et al
    Sexual and Marital Dysfunction in Women With Gynecologic Cancer.
    Int J Gynecol Cancer. 2017;27:603-607.
    Abstract    

    Abstract available

  164. LI X, Wang L, Li Y, Song P, et al
    The Value of Diffusion-Weighted Imaging in Combination With Conventional Magnetic Resonance Imaging for Improving Tumor Detection for Early Cervical Carcinoma Treated With Fertility-Sparing Surgery.
    Int J Gynecol Cancer. 2017;27:1761-1768.
    Abstract    

    Abstract available

  165. CHENG J, Hou Y, Li J, Wang W, et al
    Agreement Between Magnetic Resonance Imaging and Pathologic Findings in the Tumor Size Evaluation Before and After Neoadjuvant Chemotherapy Treatment: A Prospective Study.
    Int J Gynecol Cancer. 2017;27:1472-1479.
    Abstract    

    Abstract available

  166. LUO L, Zhang H, Nian S, Lv C, et al
    Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.
    Int J Gynecol Cancer. 2017;27:1422-1430.
    Abstract    

    Abstract available

  167. JUNG EJ, Byun JM, Kim YN, Lee KB, et al
    Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1228-1236.
    Abstract    

    Abstract available

  168. LUAN T, Hua Q, Liu X, Xu P, et al
    PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
    Int J Gynecol Cancer. 2017;27:1480-1488.
    Abstract    

    Abstract available

  169. HONG MK, Wang JH, Su CC, Li MH, et al
    Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1247-1255.
    Abstract    

    Abstract available

  170. NAIR VB, Manasa VG, Sinto MS, Jayasree K, et al
    Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Int J Gynecol Cancer. 2018;28:553-562.
    Abstract    

    Abstract available

  171. VULPE H, Asamoah FA, Maganti M, Vanderpuye V, et al
    External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
    Int J Radiat Oncol Biol Phys. 2017 Dec 21. pii: S0360-3016(17)34493.
    Abstract    

    Abstract available

  172. PEDROZA-TORRES A, Campos-Parra AD, Millan-Catalan O, Loissell-Baltazar YA, et al
    MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
    Oncol Rep. 2018 Jan 18. doi: 10.3892/or.2018.6219.
    Abstract    

    Abstract available

  173. RAMIREZ DE ARELLANO A, Riera Leal A, Lopez-Pulido EI, Gonzalez-Lucano LR, et al
    A 60 kDa prolactin variant secreted by cervical cancer cells modulates apoptosis and cytokine production.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6222.
    Abstract    

    Abstract available

  174. LI F, Wang Z, Lu G
    TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6235.
    Abstract    

    Abstract available

  175. PAPPA KI, Kontostathi G, Lygirou V, Zoidakis J, et al
    Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer (Review).
    Oncol Rep. 2018 Feb 9. doi: 10.3892/or.2018.6257.
    Abstract    

    Abstract available

  176. GERBER R, Rink A, Croke J, Borg J, et al
    Comparison of dosimetric parameters derived from whole organ and wall contours for bladder and rectum in cervical cancer patients treated with intracavitary and interstitial brachytherapy.
    Radiother Oncol. 2018 Feb 6. pii: S0167-8140(18)30041.
    Abstract    

    Abstract available

  177. COSTA RFA, Longatto-Filho A, de Lima Vazquez F, Pinheiro C, et al
    Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.
    BMC Cancer. 2018;18:126.
    Abstract    

    Abstract available

  178. SHIM SH, Lim MC, Kim HJ, Lee M, et al
    Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation.
    PLoS One. 2018;13:e0189847.
    Abstract    

    Abstract available

  179. JAUDAN A, Sharma S, Malek SNA, Dixit A, et al
    Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action.
    PLoS One. 2018;13:e0191523.
    Abstract    

    Abstract available

  180. MARKT SC, Tang T, Cronin AM, Katz IT, et al
    Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival.
    PLoS One. 2018;13:e0193047.
    Abstract    

    Abstract available

  181. HALL MT, Simms KT, Lew JB, Smith MA, et al
    Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
    PLoS One. 2018;13:e0185332.
    Abstract    

    Abstract available

  182. LAM CT, Mueller J, Asma B, Asiedu M, et al
    An integrated strategy for improving contrast, durability, and portability of a Pocket Colposcope for cervical cancer screening and diagnosis.
    PLoS One. 2018;13:e0192530.
    Abstract    

    Abstract available

  183. BROBERG G, Wang J, Ostberg AL, Adolfsson A, et al
    Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study.
    PLoS One. 2018;13:e0190171.
    Abstract    

    Abstract available

  184. LANG KUHS KA, Lin SW, Hua X, Schiffman M, et al
    T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.
    PLoS One. 2018;13:e0178167.
    Abstract    

    Abstract available

  185. SHEIKHZADEH F, Ward RK, van Niekerk D, Guillaud M, et al
    Automatic labeling of molecular biomarkers of immunohistochemistry images using fully convolutional networks.
    PLoS One. 2018;13:e0190783.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;